Related Experiment Video

Updated: May 28, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

Autophagy: an 'Achilles' heel of tumorigenesis in TSC and LAM

Jane Yu1, Andrey Parkhitko, Elizabeth Petri Henske

  • 1Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Autophagy
|October 15, 2011
PubMed

Insights

Autophagy is crucial for tumor cell survival in tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM). Inhibiting autophagy may offer new therapeutic strategies for these rare diseases.

Area of Science:

  • Cellular Biology
  • Oncology
  • Genetics

Background:

  • Mammalian target of rapamycin (mTOR) complex 1 (mTORC1) is hyperactivated in tuberous sclerosis complex (TSC) and lymphangioleiomyomatosis (LAM), regulating cell growth, metabolism, and autophagy.
  • Current mTORC1 inhibitor therapies offer partial benefits but face challenges with tumor regrowth and disease progression upon discontinuation.

Purpose of the Study:

  • To investigate the role of autophagy dysregulation in the pathogenesis of TSC and LAM tumors.
  • To explore the therapeutic potential of targeting autophagy in these conditions.

Main Methods:

  • Analysis of autophagy levels in Tsc2-deficient cells under basal and stress conditions.
  • Genetic and pharmacological manipulation of autophagy pathways.
  • Assessment of tumor cell survival in response to autophagy modulation.

Main Results:

  • Tsc2-deficient cells exhibit reduced autophagy under normal and stress conditions.
  • Tumor cell survival is dependent on induced autophagy.
  • Autophagy inhibition significantly impacts the viability of Tsc2-deficient tumor cells.

Conclusions:

  • Autophagy plays a critical role in the survival of tumor cells in TSC and LAM.
  • Autophagy inhibitors represent a promising therapeutic avenue, potentially as monotherapy or in combination with mTORC1 inhibitors for TSC and LAM.

More Related Videos

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

Related Concept Videos

Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...